17 August 2020: Clinical Research
Evaluation of Ovarian Tumors with Multidetector Computed Tomography and Tumor Markers: Differentiation of Stage I Serous Borderline Tumors and Stage I Serous Malignant Tumors Presenting as Solid-Cystic Mass
Xin-Ping Yu 1BCE , Ying Liu 2C , Jin-Wen Jiao 1D , Hong-Juan Yang 1B , Rui-Jing Wang 1D , Shuai Zhang 3ACF*DOI: 10.12659/MSM.924497
Med Sci Monit 2020; 26:e924497
Table 1 Clinical characteristics of SBOTs and SMOTs.
| Characteristic | SBOTs (n=48) | SMOTs (n=54) | P value |
|---|---|---|---|
| Age, years, median [range] | 42.0 (29.3–46.8)* | 52.0 (45–58)* | |
| Menopause | 18.8 (9/48) | 51.9 (28/54) | 0.001 |
| Clinical symptoms and signs | |||
| Abdominal distension | 12.5 (6/48) | 33.3 (18/54) | 0.013 |
| Abdominal pain | 14.6 (7/48) | 25.9 (14/54) | 0.157 |
| Increased abdominal size | 33.3 (16/48) | 16.7 (9/54) | 0.139 |
| Accidentally discovered adnexal mass by health examination | 33.3 (16/48) | 20.4 (11/54) | 0.004 |
| Abnormal vaginal bleeding | 6.3 (3/48) | 3.7 (2/54) | 0.664 |
| Duration of symptom, days, median [range] | 70.0 (21.8–340)* | 82.5 (40–150)* | 0.712 |
| Combined with breast cancer | 8.3 (4/48) | 9.3 (5/54) | 1.000 |
| Family history of tumors | 6.3 (3/48) | 9.3 (5/54) | 0.719 |
| Data are shown as % (n/N). * Data are presented as the median (inter-quartile range). SBOTs – serous borderline ovarian tumors; SMOTs – serous malignant ovarian tumors. | |||